Swine flu vaccine criminal case against STIKO

Swine flu vaccine criminal case against STIKO / Health News

Swine flu vaccine: charge of assault against STIKO

The criticism of the mass vaccination in the context of the swine flu has led on 14 January 2010 to a criminal complaint and a criminal complaint to the prosecutor's office Berlin against the Permanent Vaccination Commission (STIKO) at the Robert Koch Institute (RKI) and against unknown. Based on information from the European Medicines Agency (EMEA), the online magazine LifeGen.de states that it accuses Stiko of bodily harm, ill treatment of wards and violations of the Medicines Act.

According to this, the vaccine Pandemrix of the pharmaceutical company GlaxoSmithKline should have received its approval in May 2008 before the outbreak of the swine flu. He was tested according to LifeGen.de on 240 adult people, but probably never on children.

For the latter, however, he was recommended as compatible by the STIKO, accuses her of the magazine. Furthermore LifeGen.de states, the information of the EMEA prove that „A test phase of the vaccine on side effects and tolerability started only during the vaccination campaign“. This leads to the accusation that people who were willing to get vaccinated were not properly informed about the state of research on the drug. Next it says on the website of LifeGen.de that „usually doses of effect and studies on potential risks prior to authorization should be known“ have to.

In the United States, more than 7,800 cases of vaccination side-effects and 33 suspected cases of death have been reported via the Electronic Vaccine Reporting System (VAERS). According to LifeGen.de, this could lead to the parties filing a class action claim for damages.

Another interest in the investigation of the allegations is also from a financial point of view. LifeGen.de reports that according to the Senate Administration, the RKI was only able to update its vaccination recommendation after the beginning of the vaccination so that a single vaccination would be sufficient to protect against A / H1N1.

LifeGen.de writes that „ This changed recommendation (...) resulted in overcapacity in vaccine (...)“.

If you now consider that of the 9.6 million doses of vaccine delivered in November, almost half is left and another 34 million doses of vaccine, according to media reports, almost 300 million euros to be delivered by March 2010, then is a possible question of guilt These costs are not uninteresting. LifeGen.de calls the recommended by the STIKO and the Federal Health Minister Philipp Rösler (FDP) propagated vaccine against swine flu therefore one „large-scale test“. (Thorsten Fischer, Naturopath Osteopathy, 20.01.2010)